These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26114547)

  • 21. Antioxidative roles of metallothionein and manganese superoxide dismutase induced by tumor necrosis factor-alpha and interleukin-6.
    Sato M; Sasaki M; Hojo H
    Arch Biochem Biophys; 1995 Feb; 316(2):738-44. PubMed ID: 7532385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-edged action of SOD mimetic in diabetic nephropathy.
    Asaba K; Tojo A; Onozato ML; Goto A; Fujita T
    J Cardiovasc Pharmacol; 2007 Jan; 49(1):13-9. PubMed ID: 17261958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tetrahydrobiopterin contributes to the proliferation of mesangial cells and accumulation of extracellular matrix in early-stage diabetic nephropathy.
    Wang J; Yang Q; Nie Y; Guo H; Zhang F; Zhou X; Yin X
    J Pharm Pharmacol; 2017 Feb; 69(2):182-190. PubMed ID: 28033650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spironolactone improves nephropathy by enhancing glucose-6-phosphate dehydrogenase activity and reducing oxidative stress in diabetic hypertensive rat.
    Pessôa BS; Peixoto EB; Papadimitriou A; Lopes de Faria JM; Lopes de Faria JB
    J Renin Angiotensin Aldosterone Syst; 2012 Mar; 13(1):56-66. PubMed ID: 21987533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rescue of mesangial cells from high glucose-induced over-proliferation and extracellular matrix secretion by hydrogen sulfide.
    Yuan P; Xue H; Zhou L; Qu L; Li C; Wang Z; Ni J; Yu C; Yao T; Huang Y; Wang R; Lu L
    Nephrol Dial Transplant; 2011 Jul; 26(7):2119-26. PubMed ID: 21208996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethyl pyruvate ameliorates albuminuria and glomerular injury in the animal model of diabetic nephropathy.
    Ju KD; Shin EK; Cho EJ; Yoon HB; Kim HS; Kim H; Yang J; Hwang YH; Ahn C; Oh KH
    Am J Physiol Renal Physiol; 2012 Mar; 302(5):F606-13. PubMed ID: 22129969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of silymarin on kidneys of rats suffering from alloxan-induced diabetes mellitus.
    Soto C; Pérez J; García V; Uría E; Vadillo M; Raya L
    Phytomedicine; 2010 Dec; 17(14):1090-4. PubMed ID: 20579862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Taurine ameliorates alloxan-induced diabetic renal injury, oxidative stress-related signaling pathways and apoptosis in rats.
    Das J; Sil PC
    Amino Acids; 2012 Oct; 43(4):1509-23. PubMed ID: 22302365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of 4-phenylbutyric acid on the process and development of diabetic nephropathy induced in rats by streptozotocin: regulation of endoplasmic reticulum stress-oxidative activation.
    Luo ZF; Feng B; Mu J; Qi W; Zeng W; Guo YH; Pang Q; Ye ZL; Liu L; Yuan FH
    Toxicol Appl Pharmacol; 2010 Jul; 246(1-2):49-57. PubMed ID: 20399799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protease-activated receptor-1 deficiency protects against streptozotocin-induced diabetic nephropathy in mice.
    Waasdorp M; Duitman J; Florquin S; Spek CA
    Sci Rep; 2016 Sep; 6():33030. PubMed ID: 27618774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antioxidant N-acetylcysteine restores myocardial Mn-SOD activity and attenuates myocardial dysfunction in diabetic rats.
    Xia Z; Guo Z; Nagareddy PR; Yuen V; Yeung E; McNeill JH
    Eur J Pharmacol; 2006 Aug; 544(1-3):118-25. PubMed ID: 16859669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fucoidan exerts protective effects against diabetic nephropathy related to spontaneous diabetes through the NF-κB signaling pathway in vivo and in vitro.
    Wang Y; Nie M; Lu Y; Wang R; Li J; Yang B; Xia M; Zhang H; Li X
    Int J Mol Med; 2015 Apr; 35(4):1067-73. PubMed ID: 25672488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tetrahydroxystilbene glucoside ameliorates diabetic nephropathy in rats: involvement of SIRT1 and TGF-β1 pathway.
    Li C; Cai F; Yang Y; Zhao X; Wang C; Li J; Jia Y; Tang J; Liu Q
    Eur J Pharmacol; 2010 Dec; 649(1-3):382-9. PubMed ID: 20854812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effect of Gymnema montanum against renal damage in experimental diabetic rats.
    Ramkumar KM; Ponmanickam P; Velayuthaprabhu S; Archunan G; Rajaguru P
    Food Chem Toxicol; 2009 Oct; 47(10):2516-21. PubMed ID: 19616598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Free radical scavenging enzymes in fetal dysmorphogenesis among offspring of diabetic rats.
    Sivan E; Lee YC; Wu YK; Reece EA
    Teratology; 1997 Dec; 56(6):343-9. PubMed ID: 9485543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reactive oxygen species enhances endothelin-1 production of diabetic rat glomeruli in vitro and in vivo.
    Chen HC; Guh JY; Shin SJ; Tsai JH; Lai YH
    J Lab Clin Med; 2000 Apr; 135(4):309-15. PubMed ID: 10779046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
    Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
    Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renoprotective effect of myricetin restrains dyslipidemia and renal mesangial cell proliferation by the suppression of sterol regulatory element binding proteins in an experimental model of diabetic nephropathy.
    Kandasamy N; Ashokkumar N
    Eur J Pharmacol; 2014 Nov; 743():53-62. PubMed ID: 25240712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased glomerular and extracellular malondialdehyde levels in patients and rats with diabetic nephropathy.
    Chang JM; Kuo MC; Kuo HT; Chiu YW; Chen HC
    J Lab Clin Med; 2005 Oct; 146(4):210-5. PubMed ID: 16194682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delivery of megsin siRNA plasmid reveals therapeutic potential against diabetic nephropathy by down-regulating p27(kip1) level.
    Liu M; Zhang Y; Chi Y; Zhai S; Wang B; Shi Y; Li Y
    J Nephrol; 2012; 25(3):418-25. PubMed ID: 21928229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.